| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-3.74 (Miss by $-2.04) |
| EPS GAAP Actual | $-3.74 (Miss by $-2.04) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.49667 |
| EPS GAAP Estimate | $-0.49667 |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | -0.36 | -6.19 | -0.36 | -0.36 | 1 |
| Mar 2029 | -0.51 | -4.37 | -0.51 | -0.51 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -3.74 | -3.38 | 0B | NAN% | -0.16M |
| FQ2 2025 (Jun 2025) | -0.85 | 0.27 | 0B | NAN% | -0.17M |
| FQ1 2025 (Mar 2025) | -7.91 | -6.8 | 0.00017212B | 100% | 0.17M |
| FQ4 2024 (Dec 2024) | -125.68 | -125.49 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -201.4 | -201.21 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.34 | -1.67835 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.92 | -2.49149 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | -1377350 | -1377350 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.49667
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | -0.14 | -- | -0.14 | -0.14 | 1 |
| FQ4 2026 (Dec 2026) | -0.14 | -- | -0.14 | -0.14 | 1 |
| FQ3 2026 (Sep 2026) | -0.14 | -2571.43 | -0.14 | -0.14 | 1 |
| FQ2 2026 (Jun 2026) | -0.14 | -507.14 | -0.14 | -0.14 | 1 |
| FQ1 2026 (Mar 2026) | -0.49667 | -1492.61 | -0.49667 | -0.49667 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
| FQ1 2026 (Mar 2026) | 0B | -INF | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
2
Revenue # of in-lines
5
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.36 | -3.74 | -3.38 | 90.37% |
| FQ2 2025 (Jun 2025) | -1.12 | -0.85 | 0.27 | -31.76% |
| FQ1 2025 (Mar 2025) | -1.11 | -7.91 | -6.8 | 85.97% |
| FQ4 2024 (Dec 2024) | -0.19 | -125.68 | -125.49 | 99.85% |
| FQ3 2024 (Sep 2024) | -0.19 | -201.4 | -201.21 | 99.91% |
| FQ2 2024 (Jun 2024) | 1.33835 | -0.34 | -1.67835 | 493.63% |
| FQ1 2024 (Mar 2024) | 1.57149 | -0.92 | -2.49149 | 270.81% |
| FQ4 2023 (Dec 2023) | -1377350 | -1377350 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $-0.16M | -INF% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $-0.17M | -INF% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.17M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |